Department of Health Policy and Administration, Penn State University, University Park, Pennsylvania.
Vice-Chair of Education, Department of Radiology, Breast Imaging Division, and Medical Student Education Director, Department of Radiology, Breast Imaging Division, Penn State College of Medicine, Hershey, Pennsylvania; and ACR Commission on Economics (2019-2023), ACR Appropriateness Criteria, Lead Author, Breast Implants 2020 to present, ACR 2020 Task Force on Medical Student Education.
J Am Coll Radiol. 2022 Jan;19(1 Pt A):24-34. doi: 10.1016/j.jacr.2021.09.028. Epub 2021 Nov 5.
Although the Affordable Care Act eliminated cost sharing for screening mammography, a concern is that grandfathered plans, diagnostic mammograms, and follow-up testing may still lead to out-of-pocket (OOP) spending. Our study examines how OOP spending among women at their baseline screening mammogram may impact the decision to receive subsequent screening.
The study included commercially insured women aged 40 to 41 years with a screening mammogram between 2011 and 2014. We estimated multivariate linear probability models of the effect of OOP spending at the baseline mammogram on subsequent screening 12 to 36 months later.
Having any OOP payments for the baseline screening mammogram significantly reduced the probability of screening in the subsequent 12 to 24 months by 3.0 percentage points (pp) (95% confidence interval [CI]: 1.1-4.8 pp decrease). For every $100 increase in the OOP expenses for the baseline mammogram, the likelihood of subsequent screening within 12 to 24 months decreased by 1.9 pp (95% CI: 0.8-3.1 pp decrease). Similarly, any OOP spending for follow-up tests resulting from the baseline screening led to a 2.7 pp lower probability of screening 12 to 24 months later (95% CI: 0.9-4.1 pp decrease). Higher OOP expenses were associated with significantly lower screening 24 to 36 months later (coefficient = -0.014, 95% CI: -0.025 to -0.003).
Although cost sharing has been eliminated for screening mammograms, OOP costs may still arise, particularly for diagnostic and follow-up testing services, both of which may reduce rates of subsequent screening. For preventive services, reducing or eliminating cost sharing through policy and legislation may be important to ensuring continued adherence to screening guidelines.
尽管《平价医疗法案》取消了筛查乳房 X 光检查的共付额,但人们担心,受保计划、诊断性乳房 X 光检查和随访检查仍可能导致自费支出。我们的研究旨在探讨基线筛查乳房 X 光检查时的自费支出如何影响接受后续筛查的决策。
本研究纳入了在 2011 年至 2014 年间接受过筛查乳房 X 光检查的年龄在 40 至 41 岁的商业保险女性。我们通过多元线性概率模型估计了基线乳房 X 光检查的自费支出对随后 12 至 36 个月后筛查的影响。
基线筛查乳房 X 光检查时有任何自费支付显著降低了随后 12 至 24 个月内筛查的可能性,降低了 3.0 个百分点(95%置信区间[CI]:1.1-4.8 个百分点)。基线乳房 X 光检查自费支出每增加 100 美元,随后 12 至 24 个月内进行筛查的可能性就会降低 1.9 个百分点(95% CI:0.8-3.1 个百分点)。同样,基线筛查后因随访检查产生的任何自费支出都会导致随后 12 至 24 个月内筛查的可能性降低 2.7 个百分点(95% CI:0.9-4.1 个百分点)。较高的自费支出与随后 24 至 36 个月内筛查的可能性显著降低相关(系数=-0.014,95% CI:-0.025 至-0.003)。
尽管筛查乳房 X 光检查已取消共付额,但仍可能产生自费支出,特别是对于诊断性和随访检查服务,这两者都可能降低后续筛查的比例。对于预防性服务,通过政策和立法来降低或消除成本分担对于确保继续遵守筛查指南可能很重要。